English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [1446]
News [2944]
Articles [129]
Editorials [5]
Conferences [154]
elearning [6]
IMPAKT 2015: Constitutively activated STAT3 may be a predictive marker for resistance to trastuzumab in patients with HER2 positive breast cancer
IMPAKT 2015: Constitutively activated STAT3 may be a predictive marker for resistance to trastuzumab in patients...
DNA differences influence gene activity and disease susceptibility
DNA differences influence gene activity and disease susceptibility
New screening technique could pick up twice as many women with ovarian cancer
New screening technique could pick up twice as many women with ovarian cancer
Results demonstrate clinical value of OCT in basal cell carcinoma diagnosis
Results demonstrate clinical value of OCT in basal cell carcinoma diagnosis
Seeing the same doctor could affect time to cancer diagnosis
Seeing the same doctor could affect time to cancer diagnosis
New guidelines recommend women with rare aggressive breast cancer should be offered less invasive surgery
New guidelines recommend women with rare aggressive breast cancer should be offered less invasive surgery
'Spectral histopathology' facilitates prognosis regarding tumour aggressivenes'
'Spectral histopathology' facilitates prognosis regarding tumour aggressivenes'
Cancer gene unintentionally ends the life of cancer cells, turns off life supporting genes
Cancer gene unintentionally ends the life of cancer cells, turns off life supporting genes
AACR 2015: Evidence points to fallopian-tube origins of ovarian cancers
AACR 2015: Evidence points to fallopian-tube origins of ovarian cancers
AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations
AACR 2015: PARP inhibitor combo shows early promise for patients with and without BRCA mutations
<1...233234235236237...295>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top